Quantcast

Latest Alternative complement pathway Stories

2015-04-14 08:28:58

-- Patients with Thrombotic Microangiopathy Will Now Be Able to Receive Extended Treatment - SEATTLE, April 14, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced

2015-02-19 08:33:29

- The Company Agrees to Physician Request to Continue Treatment of Patients with aHUS - SEATTLE, Feb.

2014-11-19 08:27:47

- Data Bode Well for Success of Ongoing Phase 2 Trial in Thrombotic Microangiopathies - SEATTLE, Nov.

2014-04-03 08:29:04

-- Phase 2 Clinical Trial Planned to Begin This Quarter -- SEATTLE, April 3, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug

2014-03-10 08:29:22

- Phase 2 Clinical Trial in aHUS and Other TMAs Expected to Begin Next Quarter - SEATTLE, March 10, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive

2014-03-04 08:31:20

-- Successful Phase 1 Results Set the Stage for Trials in Patients with Life-Threatening Blood Disorders -- SEATTLE, March 4, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER)

2014-02-03 08:27:06

-- Phase 2 Program Expected to Initiate this Quarter -- SEATTLE, Feb.


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.